Author:
ÖZTÜRK Emrah,ESENER Burak,GUNDUZ Abuzer
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference16 articles.
1. 1. Lam WC, Albiani DA, Yoganathan P, et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clinical ophthalmology (Auckland, NZ). 2015;9:1255-1268.
2. 2. Wolfensberger TJ, Gregor ZJ. Macular edema--rationale for therapy. Dev Ophthalmol. 2010;47:49-58.
3. 3. Sarao V, Veritti D, Boscia F, Lanzetta P. Intravitreal steroids for the treatment of retinal diseases. ScientificWorldJournal. 2014;2014:989501.
4. 4. Kwak HW, D'Amico DJ. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol. 1992;110(2):259-266.
5. 5. Bansal R, Bansal P, Kulkarni P, Gupta V, Sharma A, Gupta A. Wandering Ozurdex((R)) implant. J Ophthalmic Inflamm Infect. 2012;2(1):1-5.